New Jersey Administrative Code
Title 10 - HUMAN SERVICES
Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES
Subchapter 11 - OPIOID TREATMENT SERVICES
Section 10:161B-11.16 - Office based opioid treatment

Universal Citation: NJ Admin Code 10:161B-11.16
Current through Register Vol. 56, No. 18, September 16, 2024

An opioid treatment program seeking to affiliate with an office based private physician for the provision of opioid treatment in the physician's office shall request an exemption from the CSAT in accordance with 42 CFR Part 8. The opioid treatment program shall also file for a waiver in accordance with N.J.A.C. 10:161B-2.13, and shall be subject to conditions imposed by DCN&L if the waiver is approved. Opioid treatment programs utilizing Suboxone shall comply with all mandates from CSAT governing the administration of Suboxone. All facilities shall comply with the DMHAS Buprenorphine Guidelines, Administrative Bulletin 2007-03, incorporated herein as chapter Appendix B.

Disclaimer: These regulations may not be the most recent version. New Jersey may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.